Clinical Trial

Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-30; most recent amendment 2026-03-09.
Status change: Not Yet Recruiting → Recruiting 2024-12-03
Trial Details
NCT Number NCT06234501
Lead Sponsor University of Reading
Collaborators: INNOPURE
Conditions Autism
Enrollment 40 participants
Start Date 2024-11-08
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-11